Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects.

Taylor DD, Gerçel-Taylor C. · 2005

Read Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. by Taylor DD, Gerçel-Taylor C. (2005) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2361848.txt.

Description

Taylor and Gerçel-Taylor studied tiny sacs shed by ovarian tumors in 2005. These sacs, called exosomes, are bits of cell membrane that tumors release. Similar sacs from immune cells help switch immunity on, and some teams hoped tumor sacs could serve as cancer vaccines.

The team collected the sacs from belly fluid of six ovarian cancer patients. Protein tests showed the sacs carried tumor markers and a molecule called FasL, which can trigger cell death. In lab tests with T cells, the immune cells that attack tumors, the sacs cut two key activation proteins, CD3-zeta and JAK3. They also drove many T cells into apoptosis, a form of programmed cell death. Two sac components, weighing 26 and 42 kilodaltons, carried the CD3-zeta effect. The authors warned the sacs may disarm immunity even while carrying vaccine material.

Catalog record

CREATORTaylor DD, Gerçel-Taylor C.
YEAR2005
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2361848

Browse the full library · About the Tower of Babel